References
- M. Kuentz and D. Rothlisberger, Determination of the optimal amount of water in liquidfill masses for hard gelatin capsules by means of texture analysis and experimental design, Int. J. Pharm. 236 (2002) 145-152; DOI: 10.1016/S0378-5173(02)00022-4.
- P. Kozlov and G. Burdygina, The structure and properties of solid gelatin and the principles of their modification, Polymer 24 (1983) 651-666; DOI: 10.1016/0032-3861(83)90001-0.
- E. T. Cole, D. Cade and H. Benameur, Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration, Adv. Drug Del. Rev. 60 (2008) 747-756; DOI: 10.1016/j.addr.2007.09.009.
- G. Reich, Effect of sorbitol specification on structure and properties of soft gelatin capsules, Pharm. Ind. 58 (1996) 941-946.
- S. Nagata, Advantages to HPMC capsules: A new generation's hard capsule, Drug Del. Technol. 2 (2002) 6-9.
- S. K. Dordunoo, J. L. Ford and M. H. Rubinstein. Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or gelucire 44/14 for liquid filling of hard gelatin capsules, Drug Dev. Ind. Pharm. 17 (1991) 1685-1713; DOI: 10.3109/03639049109057315.
- W. J. Bowtle and N. J. Barker, A new approach to vancomycin formulation using filling technology for semisolid matrix capsules, Pharm. Tech. 12 (1988) 86-97.
- Unated States Pharmacopoeia 28, National Formulary 23, USP Convention, Rockville (MD), Asian Edition, 2005.
- K. A. Shah, J. W. Warren, G. Onwuelezi, J. S. Benmaman and C. M. Monk, In vitro release of hydrochlorothiazide from capsule formulations, Drug Dev. Ind. Pharm. 7 (1981) 683-691; DOI: 10.3109/03639048109055692.
- P. R. Petrovick, M. Jacob, D. Gaudy, V. Bassani and S. Guterres, Influence of adjuvants on the in vitro dissolution of hydrochlorothiazide from hard gelatin capsules, Int. J. Pharm. 76 (1991) 49-53; DOI: 10.1016/0378-5173(91)90342-L.
- S. Miyazaki, N. Kawasaki, W. Kubo, K. Endo and D. Attwood, Comparison of in situ gelling formulations for the oral delivery of cimetidine, Int. J. Pharm. 220 (2001) 161-168; DOI: 10.1016/S0378-5173(01)00669-X.
- V. Shah, Y. Tsong, P. Sathe and J. Liu, In vitro dissolution profile comparison-statistics and analysis of the similarity factor f2, Pharm. Res. 15 (1998) 889-896; DOI: 10.1023/A:1011976615750.
- U. S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research, Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, FDA CDER, Rockwille (MD) 1997; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070237
- N. Gatchalian, L. Joseph, C. Westergom and N. Langley, Purity of PEG 400 effects the stability of gelatin capsules, American Accociation of Pharmaceutical Scientists Annual Meeting, November 6-10, 2005, Book of Abstracts, AAPS, Nashville (TN) 2005, R6012.